Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
Robotic mitral valve repair linked to benefits for elderly patients
Robotic and traditional mitral valve repair surgeries are mostly associated with similar outcomes when treating elderly patients. In some ways, however, robotic procedures may be preferred.
Vendor payments not responsible for rising popularity of LAAO procedures
Consulting fees and other vendor payments do not appear to be directly influencing U.S. physicians to implant more Watchman devices. Researcher Alexander Kolomaya, MD, discussed his team's findings on this topic.
AI predicts pediatric cancer recurrence with impressive accuracy
Researchers have developed a deep learning model that can spot longitudinal changes in patients' brain imaging that could be indicative of cancer recurrence.
AI helps cardiologists terminate AFib for good with ablation
Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care.

New research on AI-based CCTA assessments wins Best Abstract at SCCT 2023

Out of more than 250 abstracts submitted at its annual meeting in Boston, SCCT named one winner and two runners-up.

Anjali Owens, MD, medical director, Center for Inherited Cardiac Disease, associate professor of medicine at the Hospital of the University of Pennsylvania, discusses the need for standardization in HCM care. #ASE #ASE23 #ASE2023 #HCM

More consistency, standardization still needed when treating HCM

Anjali Owens, MD, discussed the past, present and future of hypertrophic cardiomyopathy care in the United States. "What we are aiming to do is develop a minimum standard for assessments of patients with HCM so they are getting properly diagnosed and managed," she explained.

Cardiologists applaud WHO’s endorsement of polypills for CVD prevention

Valentin Fuster, MD, PhD, one of the world’s most prominent cardiologists, said "it is now our responsibility to ensure these treatments are widely available and used by the medical community.”

Expanding Medicaid linked to better care for heart patients

New research, based on data from approximately 143 million patients, focused on prescriptions for heart failure, atrial fibrillation and other significant cardiac conditions.

Lisa Salberg, CEO of the Hypertrophic Cardiomyopathy Association (HCMA) explains how the group has helped improve HCM patient care.

Hypertrophic Cardiomyopathy Association has helped advance HCM care

The Hypertrophic Cardiomyopathy Association (HCMA) has helped guide and advance HCM care not only for patients, but also for hospitals and physicians.

Peter Libby, MD, explains how infections cause heart attacks. This came out of research taking a close look at COVID, but the inflammation from any infection may cause increased inflammation of coronary plaques that cause heart attacks. #COVID #COVID19

Do infections cause heart attacks? Lessons from COVID

COVID-19 opened the eyes of many cardiology researchers that infections may promote inflammation in atherosclerotic plaques, leading to cardiac events.

The 25 best U.S. cardiology hospitals ranked

U.S. News & World Report's annual rankings of heart hospitals named Cleveland Clinic No. 1, once again, but there were many changes among the other top 25 hospitals.

The team that implanted the first TaurusTrio TAVR valve at Beijing An Zhen Hospital, Capital Medical University in July 2023.

Chinese made version of JenaValve TAVR device implanted in first patient

The first patient was enrolled in a multicenter clinical trial for the TaurusTrio transcatheter aortic valve replacement system, used for aortic regurgitation.

Clinical

HHS sued over RFK’s $11B cuts to infectious disease control

Robotic mitral valve repair linked to benefits for elderly patients

Vendor payments not responsible for rising popularity of LAAO procedures

AI predicts pediatric cancer recurrence with impressive accuracy

AI helps cardiologists terminate AFib for good with ablation